Annual CFO
-$93.64 M
-$27.28 M-41.10%
December 31, 2022
Summary
- As of February 10, 2025, IMPL annual cash flow from operations is -$93.64 million, with the most recent change of -$27.28 million (-41.10%) on December 31, 2022.
- During the last 3 years, IMPL annual CFO has fallen by -$57.16 million (-156.64%).
Performance
IMPL Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFO
-$16.52 M
+$3.92 M+19.16%
September 1, 2023
Summary
- As of February 10, 2025, IMPL quarterly cash flow from operations is -$16.52 million, with the most recent change of +$3.92 million (+19.16%) on September 1, 2023.
- Over the past year, IMPL quarterly CFO has increased by +$6.15 million (+27.14%).
Performance
IMPL Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFO
-$79.09 M
+$6.15 M+7.22%
September 1, 2023
Summary
- As of February 10, 2025, IMPL TTM cash flow from operations is -$79.09 million, with the most recent change of +$6.15 million (+7.22%) on September 1, 2023.
- Over the past year, IMPL TTM CFO has increased by +$19.76 million (+19.99%).
Performance
IMPL TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
IMPL Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -41.1% | +27.1% | +20.0% |
| 3 y3 years | -156.6% | -72.7% | -173.8% |
| 5 y5 years | -156.6% | -55.4% | -644.0% |
IMPL Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | +41.1% | at low | at high | +74.1% | +19.2% | +25.0% |
| 5 y | 5-year | +156.6% | at low | +90.2% | +74.1% | +644.0% | +25.0% |
| alltime | all time | +156.6% | at low | +90.2% | +74.1% | +644.0% | +25.0% |
Impel Pharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | -$16.52 M(-19.2%) | -$79.09 M(-7.2%) |
| Jun 2023 | - | -$20.44 M(-15.3%) | -$85.25 M(-8.9%) |
| Mar 2023 | - | -$24.14 M(+34.2%) | -$93.57 M(-0.1%) |
| Dec 2022 | -$93.64 M(+41.1%) | -$17.99 M(-20.7%) | -$93.64 M(-5.3%) |
| Sep 2022 | - | -$22.68 M(-21.2%) | -$98.85 M(+5.8%) |
| Jun 2022 | - | -$28.77 M(+18.8%) | -$93.40 M(+15.8%) |
| Mar 2022 | - | -$24.21 M(+4.4%) | -$80.67 M(+21.5%) |
| Dec 2021 | -$66.36 M | -$23.19 M(+34.6%) | -$66.36 M(+24.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$17.23 M(+7.4%) | -$53.47 M(+16.7%) |
| Jun 2021 | - | -$16.03 M(+61.8%) | -$45.81 M(+19.1%) |
| Mar 2021 | - | -$9.91 M(-3.7%) | -$38.46 M(-1.8%) |
| Dec 2020 | -$39.18 M(+7.4%) | -$10.30 M(+7.6%) | -$39.18 M(+35.6%) |
| Sep 2020 | - | -$9.57 M(+10.1%) | -$28.89 M(+49.5%) |
| Jun 2020 | - | -$8.69 M(-18.3%) | -$19.32 M(+81.7%) |
| Mar 2020 | - | -$10.63 M | -$10.63 M |
| Dec 2019 | -$36.49 M | - | - |
FAQ
- What is Impel Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Impel Pharmaceuticals?
- What is Impel Pharmaceuticals annual CFO year-on-year change?
- What is Impel Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Impel Pharmaceuticals?
- What is Impel Pharmaceuticals quarterly CFO year-on-year change?
- What is Impel Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Impel Pharmaceuticals?
- What is Impel Pharmaceuticals TTM CFO year-on-year change?
What is Impel Pharmaceuticals annual cash flow from operations?
The current annual CFO of IMPL is -$93.64 M
What is the all time high annual CFO for Impel Pharmaceuticals?
Impel Pharmaceuticals all-time high annual cash flow from operations is -$36.49 M
What is Impel Pharmaceuticals annual CFO year-on-year change?
Over the past year, IMPL annual cash flow from operations has changed by -$27.28 M (-41.10%)
What is Impel Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of IMPL is -$16.52 M
What is the all time high quarterly CFO for Impel Pharmaceuticals?
Impel Pharmaceuticals all-time high quarterly cash flow from operations is -$8.69 M
What is Impel Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, IMPL quarterly cash flow from operations has changed by +$6.15 M (+27.14%)
What is Impel Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of IMPL is -$79.09 M
What is the all time high TTM CFO for Impel Pharmaceuticals?
Impel Pharmaceuticals all-time high TTM cash flow from operations is -$10.63 M
What is Impel Pharmaceuticals TTM CFO year-on-year change?
Over the past year, IMPL TTM cash flow from operations has changed by +$19.76 M (+19.99%)